In new developments and significant advances have been made in the treatment of GBM. However, despite progress, recurrence is often inevitable and patient survival remains low. A variety of factors, including tumor complexity, presence of the blood-brain barrier (BBB), and presence of GBM cancer stem cells, complicate the identification of effective treatment options and require existing therapeutic approaches to be improved. And the research will yield new therapies to improve treatment strategies for GBM.
• Tumor-derived small extracellular vesicles.
• Rindopepimut.
• Gene signature in Glioblastoma.
• Harnessing nanomedicine.
All accepted abstracts will be published in respective Allied Academies Journals.
Abstracts will be provided with Digital Object Identifier by
